Dernière mise à jour :
19/11/2024
Vasodilatateur   Isosorbide dinitrate  
injectable
Stabilité des solutions Stabilité en mélange Facteur influençant la stabilité Compatibilités Voie d’administration Bibliographie pdf
   Structure chimique  

Noms commerciaux   Noms commerciaux     

Les noms commerciaux sont donnés à titre indicatif et la composition en excipients peut être différente selon les pays et selon les laboratoires

Angsobide Malaisie
Cedocard Pays bas
Diniket Italie
Dinit Finlande
Dinitrato de isosorbida Pérou
Ekilbran Mexique
Hadirax Mexique
Isobid Pérou
Isoket Allemagne, Arabie Saoudite, Autriche, Egypte, Emirats Arabes Unis , Grande Bretagne, Hongrie, Irlande, Luxembourg, Malaisie, Mexique, Pérou, Pologne, Portugal, Suisse, Vénézuela
Isonit Equateur, Pérou
Isosorbida dinitrato Mexique
Isosorbide dinitrate Grande Bretagne, Irlande
Nitrosid Finlande
Nitrosorbide Italie
Risordan France
Sorbidilat Suisse
Zanisor Mexique
Bibliographie   injectable   Bibliographie : Isosorbide dinitrate  
Type Source
190 Revue Lee MG.
Sorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration sets.
Am J Hosp Pharm 1986 ; 43: 1945-1950.
350 Revue Martens HJ, De Goede PN, Van Loenen AC.
Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers.
Am J Hosp Pharm 1990 ; 47: 369-373.
1067 Revue Zeidler C, Dettmering D, Schrammel W, Spieteller M.
Compatibility of various drugs used in intensive care medicine in polyethylene, PVC and glass infusion containers.
EJHP 1999 ; 5: 106-110.
1102 Revue Cossum PA, Roberts MS.
Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i.v. delivery systems.
Eur J Clin Pharmacol 1981 ; 19: 181-185.
1147 Revue De Muynck C, Colardyn F, Remon JP.
Influence of intravenous administration set composition on the sorption of isosorbide dinitrate.
J Pharm Pharmacol 1991 ; 43: 601-604.
1148 Revue De Muynck C, Remon JP, Colardyn F.
The sorption of isosorbide dinitrate to intravenous delivery systems.
J Pharm Pharmacol 1988 ; 40: 601-604.
1161 Revue Allwood MC.
Sorption of parenteral nitrates during administration with a syringe pump and extension set.
Int J Pharm 1987 ; 39: 183-188.
1232 Revue Beatson C, Taylor A.
A physical compatibility study of furosemide & flucloxacillin injections.
Br J Pharm Pract 1987 ; 9: 223-226, 236.
1332 Revue Lee MG, Fenton-May V.
Absorption of isosorbide dinitrate by PVC infusion bags and administration sets.
J Clin Hosp Pharm 1981 ; 6: 209-211.
1468 Revue Sautou V, Chopineau J, Gremeau I, Chevrier R, Bruneaux F.
Compatibility with medical plastics and stability of continuously and simultaneously infused isosorbide dinitrate and heparin.
Int J Pharm 1994 ; 107: 111-119.
2141 Revue Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM.
Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units.
J Antimicrob Chemother 2003 ; 51: 651-658.
2231 Revue de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3385 Revue Raverdi V, Ampe E, Hecq JD, Tulkens PM.
Stability and compatibility of vancomycin for administration by continuous infusion.
J Antimicrob Chemother 2013 ; 68: 1179-1182.
4374 Revue Lardinois B, Dimitriou A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq J-H, Galanti L.M.
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit.
Int J Pharm Compound 2020 ;24,1:64-68
4698 Revue Ayari G, D'Huart E, Vigneron J, Demoré B.
Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs.
Pharmaceutical Technology in Hospital Pharmacy 2022

  Mentions Légales